Literature DB >> 24972766

The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.

Obul R Bandapalli1, Stephanie Schuessele1, Joachim B Kunz1, Tobias Rausch2, Adrian M Stütz2, Noa Tal3, Ifat Geron4, Nava Gershman3, Shai Izraeli3, Juliane Eilers1, Nina Vaezipour1, Renate Kirschner-Schwabe5, Jana Hof6, Arend von Stackelberg5, Martin Schrappe7, Martin Stanulla8, Martin Zimmermann9, Rolf Koehler10, Smadar Avigad11, Rupert Handgretinger12, Viktoras Frismantas13, Jean Pierre Bourquin13, Beat Bornhauser13, Jan O Korbel14, Martina U Muckenthaler15, Andreas E Kulozik15.   

Abstract

Entities:  

Keywords:  STAT5B; mutation; pediatric T-ALL

Mesh:

Substances:

Year:  2014        PMID: 24972766      PMCID: PMC4181267          DOI: 10.3324/haematol.2014.104992

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.

Authors:  Maria Kleppe; Idoya Lahortiga; Tiama El Chaar; Kim De Keersmaecker; Nicole Mentens; Carlos Graux; Katrien Van Roosbroeck; Adolfo A Ferrando; Anton W Langerak; Jules P P Meijerink; François Sigaux; Torsten Haferlach; Iwona Wlodarska; Peter Vandenberghe; Jean Soulier; Jan Cools
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

2.  Constitutive activation of STAT5 by a point mutation in the SH2 domain.

Authors:  K Ariyoshi; T Nosaka; K Yamada; M Onishi; Y Oka; A Miyajima; T Kitamura
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

3.  Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

Authors:  M Kontro; H Kuusanmäki; S Eldfors; T Burmeister; E I Andersson; O Bruserud; T H Brümmendorf; H Edgren; B T Gjertsen; M Itälä-Remes; S Lagström; O Lohi; T Lundán; J M L Martí; M M Majumder; A Parsons; T Pemovska; H Rajala; K Vettenranta; O Kallioniemi; S Mustjoki; K Porkka; C A Heckman
Journal:  Leukemia       Date:  2014-02-27       Impact factor: 11.528

4.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

5.  Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.

Authors:  Stephen Breit; Martin Stanulla; Thomas Flohr; Martin Schrappe; Wolf-Dieter Ludwig; Gabriele Tolle; Margit Happich; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Blood       Date:  2006-04-13       Impact factor: 22.113

Review 6.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.

Authors:  Lothar Hennighausen; Gertraud W Robinson
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

7.  PHF6 mutations in T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Teresa Palomero; Hossein Khiabanian; Joni Van der Meulen; Mireia Castillo; Nadine Van Roy; Barbara De Moerloose; Jan Philippé; Sara González-García; María L Toribio; Tom Taghon; Linda Zuurbier; Barbara Cauwelier; Christine J Harrison; Claire Schwab; Markus Pisecker; Sabine Strehl; Anton W Langerak; Jozef Gecz; Edwin Sonneveld; Rob Pieters; Elisabeth Paietta; Jacob M Rowe; Peter H Wiernik; Yves Benoit; Jean Soulier; Bruce Poppe; Xiaopan Yao; Carlos Cordon-Cardo; Jules Meijerink; Raul Rabadan; Frank Speleman; Adolfo Ferrando
Journal:  Nat Genet       Date:  2010-03-14       Impact factor: 38.330

8.  Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.

Authors:  Chen Shochat; Noa Tal; Obul R Bandapalli; Chiara Palmi; Ithamar Ganmore; Geertruy te Kronnie; Gunnar Cario; Giovanni Cazzaniga; Andreas E Kulozik; Martin Stanulla; Martin Schrappe; Andrea Biondi; Giuseppe Basso; Dani Bercovich; Martina U Muckenthaler; Shai Izraeli
Journal:  J Exp Med       Date:  2011-05-02       Impact factor: 14.307

9.  The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.

Authors:  C Kox; M Zimmermann; M Stanulla; S Leible; M Schrappe; W-D Ludwig; R Koehler; G Tolle; O R Bandapalli; S Breit; M U Muckenthaler; A E Kulozik
Journal:  Leukemia       Date:  2010-10-14       Impact factor: 11.528

10.  Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.

Authors:  Elisabetta Flex; Valentina Petrangeli; Lorenzo Stella; Sabina Chiaretti; Tekla Hornakova; Laurent Knoops; Cristina Ariola; Valentina Fodale; Emmanuelle Clappier; Francesca Paoloni; Simone Martinelli; Alessandra Fragale; Massimo Sanchez; Simona Tavolaro; Monica Messina; Giovanni Cazzaniga; Andrea Camera; Giovanni Pizzolo; Assunta Tornesello; Marco Vignetti; Angela Battistini; Hélène Cavé; Bruce D Gelb; Jean-Christophe Renauld; Andrea Biondi; Stefan N Constantinescu; Robin Foà; Marco Tartaglia
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

View more
  53 in total

1.  The origin of relapse in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Carmen Vicente; Jan Cools
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

Review 2.  Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology.

Authors:  Sooyeon Lee; Shannon L Kelleher
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-28       Impact factor: 4.310

3.  High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

Authors:  Emma I Andersson; Takahiro Tanahashi; Nodoka Sekiguchi; Vanessa Rebecca Gasparini; Sabrina Bortoluzzi; Toru Kawakami; Kazuyuki Matsuda; Takeki Mitsui; Samuli Eldfors; Stefania Bortoluzzi; Alessandro Coppe; Andrea Binatti; Sonja Lagström; Pekka Ellonen; Noriyasu Fukushima; Sayaka Nishina; Noriko Senoo; Hitoshi Sakai; Hideyuki Nakazawa; Yok-Lam Kwong; Thomas P Loughran; Jaroslaw P Maciejewski; Satu Mustjoki; Fumihiro Ishida
Journal:  Blood       Date:  2016-10-03       Impact factor: 22.113

4.  Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.

Authors:  Liang Huang; Dan Liu; Na Wang; Shaoping Ling; Yuting Tang; Jun Wu; Lingtong Hao; Hui Luo; Xuelian Hu; Lingshuang Sheng; Lijun Zhu; Di Wang; Yi Luo; Zhen Shang; Min Xiao; Xia Mao; Kuangguo Zhou; Lihua Cao; Lili Dong; Xinchang Zheng; Pinpin Sui; Jianlin He; Shanlan Mo; Jin Yan; Qilin Ao; Lugui Qiu; Hongsheng Zhou; Qifa Liu; Hongyu Zhang; Jianyong Li; Jie Jin; Li Fu; Weili Zhao; Jieping Chen; Xin Du; Guoliang Qing; Hudan Liu; Xin Liu; Gang Huang; Ding Ma; Jianfeng Zhou; Qian-Fei Wang
Journal:  Cell Res       Date:  2017-11-17       Impact factor: 25.617

Review 5.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

6.  Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.

Authors:  Zainul S Hasanali; Bikramajit Singh Saroya; August Stuart; Sara Shimko; Juanita Evans; Mithun Vinod Shah; Kamal Sharma; Violetta V Leshchenko; Samir Parekh; Thomas P Loughran; Elliot M Epner
Journal:  Sci Transl Med       Date:  2015-06-24       Impact factor: 17.956

7.  RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.

Authors:  Valentina Gianfelici; Sabina Chiaretti; Sofie Demeyer; Filomena Di Giacomo; Monica Messina; Roberta La Starza; Nadia Peragine; Francesca Paoloni; Ellen Geerdens; Valentina Pierini; Loredana Elia; Marco Mancini; Maria Stefania De Propris; Valerio Apicella; Gianluca Gaidano; Anna Maria Testi; Antonella Vitale; Marco Vignetti; Cristina Mecucci; Anna Guarini; Jan Cools; Robin Foà
Journal:  Haematologica       Date:  2016-05-05       Impact factor: 9.941

8.  The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.

Authors:  Darshana Kadekar; Rasmus Agerholm; John Rizk; Heidi A Neubauer; Tobias Suske; Barbara Maurer; Monica Torrellas Viñals; Elena M Comelli; Amel Taibi; Richard Moriggl; Vasileios Bekiaris
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 9.  Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Authors:  Sarah D Cramer; Peter D Aplan; Scott K Durum
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

10.  The landscape of genomic alterations across childhood cancers.

Authors:  Susanne N Gröbner; Barbara C Worst; Joachim Weischenfeldt; Ivo Buchhalter; Kortine Kleinheinz; Vasilisa A Rudneva; Pascal D Johann; Gnana Prakash Balasubramanian; Maia Segura-Wang; Sebastian Brabetz; Sebastian Bender; Barbara Hutter; Dominik Sturm; Elke Pfaff; Daniel Hübschmann; Gideon Zipprich; Michael Heinold; Jürgen Eils; Christian Lawerenz; Serap Erkek; Sander Lambo; Sebastian Waszak; Claudia Blattmann; Arndt Borkhardt; Michaela Kuhlen; Angelika Eggert; Simone Fulda; Manfred Gessler; Jenny Wegert; Roland Kappler; Daniel Baumhoer; Stefan Burdach; Renate Kirschner-Schwabe; Udo Kontny; Andreas E Kulozik; Dietmar Lohmann; Simone Hettmer; Cornelia Eckert; Stefan Bielack; Michaela Nathrath; Charlotte Niemeyer; Günther H Richter; Johannes Schulte; Reiner Siebert; Frank Westermann; Jan J Molenaar; Gilles Vassal; Hendrik Witt; Birgit Burkhardt; Christian P Kratz; Olaf Witt; Cornelis M van Tilburg; Christof M Kramm; Gudrun Fleischhack; Uta Dirksen; Stefan Rutkowski; Michael Frühwald; Katja von Hoff; Stephan Wolf; Thomas Klingebiel; Ewa Koscielniak; Pablo Landgraf; Jan Koster; Adam C Resnick; Jinghui Zhang; Yanling Liu; Xin Zhou; Angela J Waanders; Danny A Zwijnenburg; Pichai Raman; Benedikt Brors; Ursula D Weber; Paul A Northcott; Kristian W Pajtler; Marcel Kool; Rosario M Piro; Jan O Korbel; Matthias Schlesner; Roland Eils; David T W Jones; Peter Lichter; Lukas Chavez; Marc Zapatka; Stefan M Pfister
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.